生物相容性离子液体基水性胶束制剂,以提高难溶性药物的溶解度、稳定性和控释度

IF 2.5 3区 化学 Q2 CHEMISTRY, MULTIDISCIPLINARY
Md. Atikul Islam, Nishat Anjum, Md. Ataullah, Md. Abdul Muktadir Islam, Md. Nazmul Kayes, Muhammad Moniruzzaman and Md. Korban Ali
{"title":"生物相容性离子液体基水性胶束制剂,以提高难溶性药物的溶解度、稳定性和控释度","authors":"Md. Atikul Islam, Nishat Anjum, Md. Ataullah, Md. Abdul Muktadir Islam, Md. Nazmul Kayes, Muhammad Moniruzzaman and Md. Korban Ali","doi":"10.1039/D4NJ04364B","DOIUrl":null,"url":null,"abstract":"<p >The development of a universal carrier for sparingly soluble drugs (SSDs) remains a challenge to achieve an effective delivery system. To address this issue, surface active ionic liquid (SAIL)-based micellar systems have emerged as a prominent drug delivery carrier to increase the solubility of SSDs due to their exceptional physico-chemical properties. Herein, we report a new micellar formulation (MF) for SSDs (<em>e.g.</em>, naproxen, ibuprofen and rosuvastatin) comprising a biocompatible SAIL choline oleate ([Cho][Ole]). The solubility of naproxen, ibuprofen and rosuvastatin is 138, 237 and 158-fold greater, respectively, in the developed MF as compared to their solubility in water due to the presence of hydrogen-bonds, π–π interactions, and cation–π interactions between the drug and SAIL[Cho][Ole]. No indications of drug precipitation, color change, phase separation, or flocculation as well as no discernible change in the quantity of NAP were found indicating the exceptional stability of NAP-loaded MF. <em>In vitro</em> release studies of NAP-loaded MF were carried out using phosphate-buffered saline (PBS) with dialysis membranes, simulating the buffering conditions of physiological body fluids. This experiment showed a 50–60% burst release of NAP within the first 4 hours, with no substantial release after 12 hours, suggesting a sustained release of NAP. Furthermore, cytotoxicity studies of SAIL[Cho][Ole]-based MFs were conducted to evaluate the relative safety effect of the MF. The result was found that the LC<small><sub>50</sub></small> of SAIL[Cho][Ole] was 73.33 μg mL<small><sup>−1</sup></small> whereas that of the positive control was 0.159 μg mL<small><sup>−1</sup></small>, indicating the lower toxicity of SAIL[Cho][Ole]. These results clearly suggest that the SAIL[Cho][Ole]-based aqueous MFs represent a promising substitute to conventional surfactant-based MFs and can be used as a biocompatible carrier for SSDs as well as a valuable strategy for drug delivery systems at different therapeutic areas.</p>","PeriodicalId":95,"journal":{"name":"New Journal of Chemistry","volume":" 8","pages":" 3318-3327"},"PeriodicalIF":2.5000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Biocompatible ionic liquid-based aqueous micellar formulation to enhance solubility, stability and controlled release of sparingly soluble drugs†\",\"authors\":\"Md. Atikul Islam, Nishat Anjum, Md. Ataullah, Md. Abdul Muktadir Islam, Md. Nazmul Kayes, Muhammad Moniruzzaman and Md. Korban Ali\",\"doi\":\"10.1039/D4NJ04364B\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >The development of a universal carrier for sparingly soluble drugs (SSDs) remains a challenge to achieve an effective delivery system. To address this issue, surface active ionic liquid (SAIL)-based micellar systems have emerged as a prominent drug delivery carrier to increase the solubility of SSDs due to their exceptional physico-chemical properties. Herein, we report a new micellar formulation (MF) for SSDs (<em>e.g.</em>, naproxen, ibuprofen and rosuvastatin) comprising a biocompatible SAIL choline oleate ([Cho][Ole]). The solubility of naproxen, ibuprofen and rosuvastatin is 138, 237 and 158-fold greater, respectively, in the developed MF as compared to their solubility in water due to the presence of hydrogen-bonds, π–π interactions, and cation–π interactions between the drug and SAIL[Cho][Ole]. No indications of drug precipitation, color change, phase separation, or flocculation as well as no discernible change in the quantity of NAP were found indicating the exceptional stability of NAP-loaded MF. <em>In vitro</em> release studies of NAP-loaded MF were carried out using phosphate-buffered saline (PBS) with dialysis membranes, simulating the buffering conditions of physiological body fluids. This experiment showed a 50–60% burst release of NAP within the first 4 hours, with no substantial release after 12 hours, suggesting a sustained release of NAP. Furthermore, cytotoxicity studies of SAIL[Cho][Ole]-based MFs were conducted to evaluate the relative safety effect of the MF. The result was found that the LC<small><sub>50</sub></small> of SAIL[Cho][Ole] was 73.33 μg mL<small><sup>−1</sup></small> whereas that of the positive control was 0.159 μg mL<small><sup>−1</sup></small>, indicating the lower toxicity of SAIL[Cho][Ole]. These results clearly suggest that the SAIL[Cho][Ole]-based aqueous MFs represent a promising substitute to conventional surfactant-based MFs and can be used as a biocompatible carrier for SSDs as well as a valuable strategy for drug delivery systems at different therapeutic areas.</p>\",\"PeriodicalId\":95,\"journal\":{\"name\":\"New Journal of Chemistry\",\"volume\":\" 8\",\"pages\":\" 3318-3327\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-01-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"New Journal of Chemistry\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://pubs.rsc.org/en/content/articlelanding/2025/nj/d4nj04364b\",\"RegionNum\":3,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"New Journal of Chemistry","FirstCategoryId":"92","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/nj/d4nj04364b","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

摘要

少溶性药物(ssd)通用载体的开发仍然是实现有效递送系统的挑战。为了解决这个问题,基于表面活性离子液体(SAIL)的胶束系统由于其特殊的物理化学性质而成为一种突出的药物递送载体,以增加固态硬盘的溶解度。在此,我们报道了一种新的固态硬盘胶束配方(MF)(例如,萘普生,布洛芬和瑞舒伐他汀),包括生物相容性SAIL胆碱油酸盐([Cho][Ole])。由于药物与SAIL之间存在氢键、π -π相互作用和阳离子-π相互作用[Cho][Ole],萘普生、布洛芬和瑞舒伐他汀在发育的MF中的溶解度分别是其在水中溶解度的138倍、237倍和158倍。没有发现药物沉淀、颜色变化、相分离或絮凝的迹象,也没有发现NAP数量的明显变化,这表明NAP负载MF具有特殊的稳定性。采用带透析膜的磷酸盐缓冲盐水(PBS)模拟生理体液的缓冲条件,进行了nap负载MF的体外释放研究。本实验显示,NAP在前4小时内有50-60%的爆发性释放,12小时后无明显释放,提示NAP持续释放。此外,还进行了SAIL[Cho][Ole]基MF的细胞毒性研究,以评估MF的相对安全性。结果发现SAIL[Cho][Ole]的LC50为73.33 μ mL−1,而阳性对照的LC50为0.159 μ mL−1,表明SAIL[Cho][Ole]的毒性较低。这些结果清楚地表明,SAIL[Cho][Ole]基水性基质是传统表面活性剂基基质的有前途的替代品,可以用作固态硬盘的生物相容性载体,也可以作为不同治疗领域的药物输送系统的有价值的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Biocompatible ionic liquid-based aqueous micellar formulation to enhance solubility, stability and controlled release of sparingly soluble drugs†

Biocompatible ionic liquid-based aqueous micellar formulation to enhance solubility, stability and controlled release of sparingly soluble drugs†

The development of a universal carrier for sparingly soluble drugs (SSDs) remains a challenge to achieve an effective delivery system. To address this issue, surface active ionic liquid (SAIL)-based micellar systems have emerged as a prominent drug delivery carrier to increase the solubility of SSDs due to their exceptional physico-chemical properties. Herein, we report a new micellar formulation (MF) for SSDs (e.g., naproxen, ibuprofen and rosuvastatin) comprising a biocompatible SAIL choline oleate ([Cho][Ole]). The solubility of naproxen, ibuprofen and rosuvastatin is 138, 237 and 158-fold greater, respectively, in the developed MF as compared to their solubility in water due to the presence of hydrogen-bonds, π–π interactions, and cation–π interactions between the drug and SAIL[Cho][Ole]. No indications of drug precipitation, color change, phase separation, or flocculation as well as no discernible change in the quantity of NAP were found indicating the exceptional stability of NAP-loaded MF. In vitro release studies of NAP-loaded MF were carried out using phosphate-buffered saline (PBS) with dialysis membranes, simulating the buffering conditions of physiological body fluids. This experiment showed a 50–60% burst release of NAP within the first 4 hours, with no substantial release after 12 hours, suggesting a sustained release of NAP. Furthermore, cytotoxicity studies of SAIL[Cho][Ole]-based MFs were conducted to evaluate the relative safety effect of the MF. The result was found that the LC50 of SAIL[Cho][Ole] was 73.33 μg mL−1 whereas that of the positive control was 0.159 μg mL−1, indicating the lower toxicity of SAIL[Cho][Ole]. These results clearly suggest that the SAIL[Cho][Ole]-based aqueous MFs represent a promising substitute to conventional surfactant-based MFs and can be used as a biocompatible carrier for SSDs as well as a valuable strategy for drug delivery systems at different therapeutic areas.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
New Journal of Chemistry
New Journal of Chemistry 化学-化学综合
CiteScore
5.30
自引率
6.10%
发文量
1832
审稿时长
2 months
期刊介绍: A journal for new directions in chemistry
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信